Sterlite Technologies (STL) delivered record Q2 FY27 performance, with revenue surging to Rs 2,529 crore and EBITDA reaching Rs 846 crore. The company is now net debt-free, backed by a massive Rs 35,274 crore order book. While the company achieved an 'AA/Stable' rating upgrade from CRISIL, investors should note pending US litigation involving a subsidiary.
Sterlite Technologies Reports Record Q2 FY27 Financials
Revenue: Rs 2,529 crore (vs Rs 1,034 crore in Q2 FY26)
PAT: Rs 517 crore (vs Rs 4 crore in Q2 FY26)
Reader Takeaway: Strong revenue and net debt-free status bolster growth, while US legal disputes remain a key risk.
What just happened
Sterlite Technologies (STL) posted its highest-ever quarterly financial performance in Q2 FY27. Revenue jumped 145% year-on-year to Rs 2,529 crore, while EBITDA surged to Rs 846 crore. The bottom line was significantly bolstered by a one-time US tariff refund gain of Rs 161 crore, leading to a net profit of Rs 517 crore. Reflecting these improvements, CRISIL upgraded the company’s long-term rating to 'AA/Stable'.
Why this matters
Achieving a net debt-free balance sheet is a landmark shift for the company, providing financial flexibility to pursue its 'Lakshya' roadmap, which aims for Rs 20,000 crore in revenue by FY29. The record-high open order book of Rs 35,274 crore—driven by major multi-year agreements worth over $2.3 billion—offers clear earnings visibility in the medium term.
The backstory
The company has been aggressively focusing on scaling its AI-ready digital infrastructure. Recent major wins with global telecom operators and hyperscalers have been central to this growth trajectory, helping the company transition from high-debt levels to a debt-free status within a relatively short period.
Risks to watch
A primary concern remains the ongoing litigation in the United States involving the subsidiary, Sterlite Technologies Inc. A jury verdict has been delivered against the subsidiary, and while the company is currently pursuing legal appeals, the final financial impact of this case remains uncertain.
What to track next
Investors should monitor the execution of the massive order book and the company's ability to maintain EBITDA margins above 30% as per their long-term guidance. Additionally, any updates regarding the US legal appeal process will be essential for assessing long-term liability.
